Long Non-Coding RNA AL139385.1 as a Novel Prognostic Biomarker in Lung Adenocarcinoma

被引:4
|
作者
Chen, Xi [1 ]
Guo, Jishu [2 ]
Zhou, Fan [3 ]
Ren, Wenjun [4 ]
Huang, Xiaobin [1 ]
Pu, Jun [1 ]
Niu, Xiaoqun [5 ]
Jiang, Xiulin [6 ]
机构
[1] Kunming Med Univ, Affiliated Hosp 2, Dept Neurosurg, Kunming, Peoples R China
[2] Yunnan Univ, Inst forEcol Res & Pollut Control Plateau Lakes, Sch Ecol & Environm Sci, Kunming, Peoples R China
[3] Puer Peoples Hosp, Hematol & Rheumatol Dept, Puer, Peoples R China
[4] First Peoples Hosp Yunnan Prov, Dept Cardiovasc Surg, Kunming, Peoples R China
[5] Kunming Med Univ, Second Hosp, Dept Resp Med, Kunming, Peoples R China
[6] Univ Chinese Acad Sci, Kunming Coll Life Sci, Beijing, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2022年 / 12卷
关键词
AL139385; 1; lung adenocarcinoma; prognosis biomarker; DNA methylation; ceRNA; cell proliferation; cell migration; CELL-PROLIFERATION; CANCER; RETRACTION; EXPRESSION;
D O I
10.3389/fonc.2022.905871
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Lung adenocarcinoma (LUAD) is the most common histological lung cancer, and it is the leading cause of cancer-related deaths worldwide. LncRNA-AL139385.1 (ENSG00000275880) is a novel lncRNA that is abnormally expressed in various cancer types including LUAD. However, the underlying biological function and potential mechanisms of AL139385.1 driving the progression of LUAD remain unclear. In this study, we investigated the role of AL139385.1 in LUAD and found that DNA hypomethylation was positively correlated with AL139385.1 expression in LUAD. Moreover, we uncover that the expression of AL139385.1 in LUAD tissues was significantly higher than that of AL139385.1 expression in adjacent normal tissues. Kaplan-Meier survival analysis showed that patients with higher AL139385.1 expression correlated with adverse overall survival and progression-free survival. Receiver operating characteristic (ROC) curve analysis showed that the area under the curve (AUC) value of AL139385.1 was 0.808. Correlation analysis showed that AL139385.1 expression was associated with immune infiltration in LUAD. We also found that AL139385.1 was upregulated in LUAD cancer tissues and cell lines. Knockdown of AL139385.1 significantly inhibited cell proliferation and migration abilities of LUAD. Finally, we constructed a ceRNA network that includes hsa-miR-532-5p and four mRNAs (GALNT3, CYCS, EIF5A, and ITGB4) specific to AL139385.1 in LUAD. Subsequent Kaplan-Meier survival analysis suggested that polypeptide N-acetylgalactosaminyltransferase 3 (GALNT3), cytochrome c, somatic (CYCS), eukaryotic translation initiation factor 5A (EIF5A), and integrin subunit beta 4 (ITGB4), were potential prognostic biomarkers for patients with LUAD. In conclusion, this finding provides possible mechanisms underlying the abnormal upregulation of AL139385.1 as well as a comprehensive view of the AL139385.1-mediated competing endogenous RNAs (ceRNA) network in LUAD, thereby highlighting its potential role in diagnosis and therapy.
引用
收藏
页数:16
相关论文
共 50 条
  • [1] Long non-coding RNA AL139385.1 as a novel prognostic biomarker in lung adenocarcinoma ( vol 12 , 905871 , 2022)
    Chen, Xi
    Guo, Jishu
    Zhou, Fan
    Ren, Wenjun
    Huang, Xiaobin
    Pu, Jun
    Niu, Xiaoqun
    Jiang, Xiulin
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [2] Long non-coding RNA FAM230B is a novel prognostic and diagnostic biomarker for lung adenocarcinoma
    Cao, Yu
    Zhang, Hong
    Tang, Jianming
    Wang, Rui
    BIOENGINEERED, 2022, 13 (03) : 7919 - 7925
  • [3] Long non-coding RNA RFPL3S is a novel prognostic biomarker in lung cancer
    Liu, Zhonghua
    Ning, Zhiqiang
    Lu, Hailin
    Cao, Tinghua
    Zhou, Feng
    Ye, Xia
    Chen, Chao
    ONCOLOGY LETTERS, 2020, 20 (02) : 1270 - 1280
  • [4] Long Non-Coding RNA AP000695.2 Acts as a Novel Prognostic Biomarker and Regulates the Cell Growth and Migration of Lung Adenocarcinoma
    Wang, Chunyan
    Guo, Jishu
    Jiang, Rongyan
    Wang, Chenyang
    Pan, Chenglong
    Nie, Zhi
    Jiang, Xiulin
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2022, 9
  • [5] Competitive endogenous RNA network identifies four long non-coding RNA signature as a candidate prognostic biomarker for lung adenocarcinoma
    Hu, Jing
    Wang, Tonglian
    Chen, Qiang
    TRANSLATIONAL CANCER RESEARCH, 2019, 8 (04) : 1046 - +
  • [6] Development of a novel prognostic signature of long non-coding RNAs in lung adenocarcinoma
    Zheng, Shanbo
    Zheng, Difan
    Dong, Chuanpeng
    Jiang, Jiahua
    Xie, Juntao
    Sun, Yihua
    Chen, Haiquan
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2017, 143 (09) : 1649 - 1657
  • [7] Development of a novel prognostic signature of long non-coding RNAs in lung adenocarcinoma
    Shanbo Zheng
    Difan Zheng
    Chuanpeng Dong
    Jiahua Jiang
    Juntao Xie
    Yihua Sun
    Haiquan Chen
    Journal of Cancer Research and Clinical Oncology, 2017, 143 : 1649 - 1657
  • [8] Identification and validation of an autophagy-related long non-coding RNA signature as a prognostic biomarker for patients with lung adenocarcinoma
    Jiang, Aimin
    Liu, Na
    Bai, Shuheng
    Wang, Jingjing
    Gao, Huan
    Zheng, Xiaoqiang
    Fu, Xiao
    Ren, Mengdi
    Zhang, Xiaoni
    Tian, Tao
    Ruan, Zhiping
    Liang, Xuan
    Yao, Yu
    JOURNAL OF THORACIC DISEASE, 2021, 13 (02) : 720 - 734
  • [9] Identification of anoikis-related long non-coding RNA signature as a novel prognostic model in lung adenocarcinoma
    Fang, Xisheng
    Wei, Mei
    Liu, Xia
    Lu, Lin
    Liu, Guolong
    TRANSLATIONAL CANCER RESEARCH, 2024, 13 (10)
  • [10] Long non-coding RNA Fendrr as biomarker for lung cancer
    Herrera, Antonio
    Cuadros, Marta
    Rodriguez, Sandra
    Torres, Raul
    Farez, Esther
    Medina, Pedro
    CANCER RESEARCH, 2016, 76